Reported 0 shares, down 964,818 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-03-31 | 3278000 |
| 2021-06-30 | 3381000 |
| 2021-09-30 | 2800000 |
| 2021-12-31 | 1302000 |
| 2022-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2022 | Reduced | 0 | -964,818 (-100.0%) | 0 | $0 | 2022-05-13 | |
| Q4 2021 | Added | 964,818 | +2,619 (0.3%) | < 0.01% | $1,302,000 | 2022-02-14 | |
| Q3 2021 | Reduced | 962,199 | -6,488 (-0.7%) | < 0.01% | $2,800,000 | 2021-11-12 | |
| Q2 2021 | Added | 968,687 | +10,100 (1.1%) | < 0.01% | $3,381,000 | 2021-08-13 | |
| Q1 2021 | Reduced | 958,587 | -10,052 (-1.0%) | < 0.01% | $3,278,000 | 2021-05-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
50 managers reported ODONATE THERAPEUTICS INC COM ( for Q1 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Boxer Capital LLC | Unchanged | 4,207,086 | 0 | 0.29% | $5,553,000 | 18 qtrs |
| Samsara BioCapital LLC | Unchanged | 700,421 | 0 | 0.23% | $925,000 | 14 qtrs |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 384,995 | -31,744 | < 0.01% | $506,000 | 5 qtrs |
| Hennion & Walsh Asset Management Inc | Reduced | 69,264 | -3,486 | < 0.01% | $91,000 | 5 qtrs |
| Tower Research Capital LLC TRC | Reduced | 43,163 | -2,607 | < 0.01% | $57,000 | 9 qtrs |
| SIMPLEX TRADING LLC | Reduced | 2,000 | -6,982 | < 0.01% | $2,000 | 8 qtrs |
| TWO SIGMA ADVISERS LP | Reduced | 0 | -243,793 | 0 | $0 | 11 qtrs |
| XTX Topco Ltd | Reduced | 0 | -11,714 | 0 | $0 | 2 qtrs |
| FEDERATED HERMES INC | Reduced | 0 | -4,279 | 0 | $0 | 3 qtrs |
| Ikarian Capital LLC | Reduced | 0 | -1,340,631 | 0 | $0 | 5 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2022
- Filed
- May 13, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.